These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

232 related articles for article (PubMed ID: 24008822)

  • 1. Topical 0.03% tacrolimus preventing rejection in high-risk corneal transplantation: a cohort study.
    Magalhaes OA; Marinho DR; Kwitko S
    Br J Ophthalmol; 2013 Nov; 97(11):1395-8. PubMed ID: 24008822
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficacy and safety of long-term corticosteroid eye drops after penetrating keratoplasty: a prospective, randomized, clinical trial.
    Shimazaki J; Iseda A; Satake Y; Shimazaki-Den S
    Ophthalmology; 2012 Apr; 119(4):668-73. PubMed ID: 22264885
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy of topical cyclosporine 0.05% for prevention of cornea transplant rejection episodes.
    Price MO; Price FW
    Ophthalmology; 2006 Oct; 113(10):1785-90. PubMed ID: 16884779
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Long-term results of FK 506 eye drops following corneal transplantation].
    Reis A; Mayweg S; Birnbaum F; Reinhard T
    Klin Monbl Augenheilkd; 2008 Jan; 225(1):57-61. PubMed ID: 18236371
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tacrolimus Eye Drops as Adjunct Therapy in Severe Corneal Endothelial Rejection Refractory to Corticosteroids.
    Ghaffari R; Ghassemi H; Zarei-Ghanavati M; Latifi G; Dehghani S; Haq Z; Djalilian AR
    Cornea; 2017 Oct; 36(10):1195-1199. PubMed ID: 28817391
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Interim results from the prospective "Erlanger Non-high-risk Penetrating Keratoplasty Study" in 207 patients].
    Graupner M; Seitz B; Langenbucher A; Martus P; Blüthner K; Nguyen NX; Wenkel H; Küchle M
    Klin Monbl Augenheilkd; 2000 Sep; 217(3):163-70. PubMed ID: 11076347
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Combined penetrating keratoplasty with keratolimbal allograft transplantation in the treatment of severe corneal burns].
    Shi WY; Gao H; Wang FH; Jin XM; Xie LX
    Zhonghua Yan Ke Za Zhi; 2005 May; 41(5):394-8. PubMed ID: 15938800
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Indications, outcomes, and risk factors for failure in tectonic keratoplasty.
    Ang M; Mehta JS; Sng CC; Htoon HM; Tan DT
    Ophthalmology; 2012 Jul; 119(7):1311-9. PubMed ID: 22541633
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Large-diameter penetrating keratoplasty: indications and outcomes.
    Skeens HM; Holland EJ
    Cornea; 2010 Mar; 29(3):296-301. PubMed ID: 20118782
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [The observation of tacrolimus eye drops preventing the early immunological rejection after penetrating keratoplasty for fungal keratitis].
    Xiang DM; Wang YX; Jia YN; Li SX; Zhai HL; Shi WY; Gao H
    Zhonghua Yan Ke Za Zhi; 2017 Apr; 53(4):305-310. PubMed ID: 28412805
    [No Abstract]   [Full Text] [Related]  

  • 11. The modified Cincinnati procedure: combined conjunctival limbal autografts and keratolimbal allografts for severe unilateral ocular surface failure.
    Chan CC; Biber JM; Holland EJ
    Cornea; 2012 Nov; 31(11):1264-72. PubMed ID: 22406944
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Graft rejection and graft failure after penetrating keratoplasty or posterior lamellar keratoplasty for fuchs endothelial dystrophy.
    Hjortdal J; Pedersen IB; Bak-Nielsen S; Ivarsen A
    Cornea; 2013 May; 32(5):e60-3. PubMed ID: 23086366
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long-term comparison of full-bed deep lamellar keratoplasty with penetrating keratoplasty in treating corneal leucoma caused by herpes simplex keratitis.
    Wu SQ; Zhou P; Zhang B; Qiu WY; Yao YF
    Am J Ophthalmol; 2012 Feb; 153(2):291-299.e2. PubMed ID: 21996306
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical outcomes of penetrating keratoplasty after autologous cultivated limbal epithelial transplantation for ocular surface burns.
    Basu S; Mohamed A; Chaurasia S; Sejpal K; Vemuganti GK; Sangwan VS
    Am J Ophthalmol; 2011 Dec; 152(6):917-924.e1. PubMed ID: 21851920
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-term rejection incidence and reversibility after penetrating and lamellar keratoplasty.
    Guilbert E; Bullet J; Sandali O; Basli E; Laroche L; Borderie VM
    Am J Ophthalmol; 2013 Mar; 155(3):560-569.e2. PubMed ID: 23218931
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Limbal autograft and allograft transplantations in patients with corneal burns.
    Ozdemir O; Tekeli O; Ornek K; Arslanpençe A; Yalçindağ NF
    Eye (Lond); 2004 Mar; 18(3):241-8. PubMed ID: 15004571
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-term topical steroid treatment improves graft survival following normal-risk penetrating keratoplasty.
    Nguyen NX; Seitz B; Martus P; Langenbucher A; Cursiefen C
    Am J Ophthalmol; 2007 Aug; 144(2):318-9. PubMed ID: 17659972
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Topical tacrolimus for high-risk corneal transplantation: a randomized, clinical trial.
    Shimazaki J; Tomida D; Yagi-Yaguchi Y; Satake Y; Yamaguchi T
    BMC Ophthalmol; 2024 Jun; 24(1):251. PubMed ID: 38867175
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Deep anterior lamellar keratoplasty using acellular corneal tissue for prevention of allograft rejection in high-risk corneas.
    Li J; Yu L; Deng Z; Wang L; Sun L; Ma H; Chen W
    Am J Ophthalmol; 2011 Nov; 152(5):762-70.e3. PubMed ID: 21803324
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Keratoplasty postoperative treatment update.
    Shimmura-Tomita M; Shimmura S; Satake Y; Shimazaki-Den S; Omoto M; Tsubota K; Shimazaki J
    Cornea; 2013 Nov; 32 Suppl 1():S60-4. PubMed ID: 24104936
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.